pharmaobservatory 0.1.4 → 0.1.6

This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
Files changed (325) hide show
  1. checksums.yaml +4 -4
  2. data/README.md +118 -7
  3. data/docs/ApiV1WhoamiGet200Response.md +13 -1
  4. data/docs/ApiV1WhoamiGet200ResponseLimits.md +32 -0
  5. data/docs/ApiV1WhoamiGet200ResponseQuota.md +20 -0
  6. data/docs/ApiV1WhoamiGet200ResponseQuotaBuckets.md +28 -0
  7. data/docs/ApiV1WhoamiGet200ResponseQuotaBucketsRequestsPerMinute.md +28 -0
  8. data/docs/BiomarkerAssayEvidenceResponse.md +58 -0
  9. data/docs/{BiomarkerCdxAssertionsResponseBuild.md → BiomarkerAssayEvidenceResponseBuild.md} +2 -2
  10. data/docs/{BiomarkerCdxAssertionsResponseFreshness.md → BiomarkerAssayEvidenceResponseFreshness.md} +2 -2
  11. data/docs/{BiomarkerCdxAssertionsResponseScope.md → BiomarkerAssayEvidenceResponseScope.md} +2 -2
  12. data/docs/BiomarkerAssayEvidenceRow.md +68 -0
  13. data/docs/BiomarkerAssayWhitespaceResponse.md +58 -0
  14. data/docs/BiomarkerAssayWhitespaceRow.md +66 -0
  15. data/docs/BiomarkerBqpAssertionsResponse.md +3 -3
  16. data/docs/BiomarkerCdxAssertionsResponse.md +3 -3
  17. data/docs/BiomarkerEvidenceResponse.md +3 -3
  18. data/docs/BiomarkerLiteratureResponse.md +3 -3
  19. data/docs/BiomarkerPublishingCompaniesResponse.md +3 -3
  20. data/docs/BiomarkerPublishingCompaniesRow.md +9 -1
  21. data/docs/BiomarkerRelationsResponse.md +3 -3
  22. data/docs/BiomarkerSampleCoverageResponse.md +3 -3
  23. data/docs/BiomarkerSamplePrevalenceResponse.md +3 -3
  24. data/docs/BiomarkerValidationResponse.md +3 -3
  25. data/docs/BiomarkerVariantMentionsResponse.md +3 -3
  26. data/docs/BiomarkersApi.md +160 -0
  27. data/docs/BiomarkersRecord.md +2 -2
  28. data/docs/BiomarkersResponse.md +3 -3
  29. data/docs/BiomarkersRow.md +2 -0
  30. data/docs/CellLinesRecord.md +2 -2
  31. data/docs/CellLinesResponse.md +3 -3
  32. data/docs/CompaniesApi.md +246 -0
  33. data/docs/CompaniesRecord.md +2 -2
  34. data/docs/CompaniesResponse.md +3 -3
  35. data/docs/CompaniesRow.md +1 -1
  36. data/docs/CompanyAssetsResponse.md +3 -3
  37. data/docs/CompanyFundingEventsResponse.md +3 -3
  38. data/docs/CompanyFundingEventsRow.md +1 -1
  39. data/docs/CompanyFundingSummaryResponse.md +3 -3
  40. data/docs/CompanyMembersResponse.md +3 -3
  41. data/docs/CompanyProgramsResponse.md +3 -3
  42. data/docs/CompanyTargetsResponse.md +3 -3
  43. data/docs/CompanyTargetsRow.md +5 -1
  44. data/docs/ConditionAdverseEventsResponse.md +3 -3
  45. data/docs/ConditionBurdenResponse.md +3 -3
  46. data/docs/ConditionDeliveryResponse.md +3 -3
  47. data/docs/ConditionDrugsResponse.md +3 -3
  48. data/docs/ConditionPrevalenceResponse.md +3 -3
  49. data/docs/ConditionPrevalenceRow.md +1 -1
  50. data/docs/ConditionPublicationsResponse.md +3 -3
  51. data/docs/ConditionRecruitmentByPhaseResponse.md +58 -0
  52. data/docs/ConditionRecruitmentByPhaseRow.md +50 -0
  53. data/docs/ConditionRecruitmentDurationResponse.md +58 -0
  54. data/docs/ConditionRecruitmentDurationRow.md +86 -0
  55. data/docs/ConditionSitesResponse.md +3 -3
  56. data/docs/ConditionTrialStartForecastResponse.md +58 -0
  57. data/docs/ConditionTrialStartForecastRow.md +70 -0
  58. data/docs/ConditionTrialsResponse.md +3 -3
  59. data/docs/ConditionTrialsRow.md +4 -2
  60. data/docs/ConditionsApi.md +240 -0
  61. data/docs/ConditionsRecord.md +2 -2
  62. data/docs/ConditionsRecordAttributes.md +3 -1
  63. data/docs/ConditionsResponse.md +3 -3
  64. data/docs/DrugPatentCliffResponse.md +3 -3
  65. data/docs/InstitutionalHoldingsResponse.md +3 -3
  66. data/docs/InstitutionalHoldingsRow.md +7 -1
  67. data/docs/InvestorFundsResponse.md +58 -0
  68. data/docs/InvestorFundsRow.md +24 -0
  69. data/docs/InvestorPortfolioResponse.md +58 -0
  70. data/docs/InvestorPortfolioRow.md +42 -0
  71. data/docs/InvestorPrivateFundsResponse.md +58 -0
  72. data/docs/InvestorPrivateFundsRow.md +44 -0
  73. data/docs/InvestorsApi.md +633 -0
  74. data/docs/InvestorsRecord.md +38 -0
  75. data/docs/InvestorsResponse.md +58 -0
  76. data/docs/InvestorsRow.md +54 -0
  77. data/docs/LegalEntitiesApi.md +240 -0
  78. data/docs/LegalEntitiesRecord.md +2 -2
  79. data/docs/LegalEntitiesResponse.md +3 -3
  80. data/docs/LegalEntitiesRow.md +1 -1
  81. data/docs/ManagersApi.md +233 -0
  82. data/docs/ManagersRecord.md +38 -0
  83. data/docs/ManagersResponse.md +58 -0
  84. data/docs/ManagersRow.md +46 -0
  85. data/docs/OrgDisclosuresResponse.md +58 -0
  86. data/docs/OrgDisclosuresRow.md +56 -0
  87. data/docs/OrgRelationshipsResponse.md +58 -0
  88. data/docs/OrgRelationshipsRow.md +68 -0
  89. data/docs/OwnershipPositionsResponse.md +3 -3
  90. data/docs/OwnershipPositionsRow.md +16 -14
  91. data/docs/PdufaDatesResponse.md +3 -3
  92. data/docs/SiteBedsYearlyResponse.md +3 -3
  93. data/docs/SiteCroTrialsResponse.md +3 -3
  94. data/docs/SiteHospitalsResponse.md +3 -3
  95. data/docs/SiteInvestigatorsResponse.md +3 -3
  96. data/docs/SiteTrialConditionsResponse.md +3 -3
  97. data/docs/SiteTrialDrugsResponse.md +3 -3
  98. data/docs/SiteTrialsResponse.md +3 -3
  99. data/docs/SiteTrialsRow.md +3 -1
  100. data/docs/SitesRecord.md +2 -2
  101. data/docs/SitesResponse.md +3 -3
  102. data/docs/SponsorRecruitmentByPhaseResponse.md +3 -3
  103. data/docs/SponsorRecruitmentDurationResponse.md +3 -3
  104. data/docs/SponsorTrialStartForecastResponse.md +3 -3
  105. data/docs/SponsorTrialsResponse.md +3 -3
  106. data/docs/SponsorTrialsRow.md +4 -2
  107. data/docs/SupplierCapabilityEsgResponse.md +58 -0
  108. data/docs/SupplierCapabilityEsgRow.md +64 -0
  109. data/docs/SupplierServicesResponse.md +58 -0
  110. data/docs/SupplierServicesRow.md +30 -0
  111. data/docs/SupplierSitesResponse.md +58 -0
  112. data/docs/SupplierSitesRow.md +42 -0
  113. data/docs/SuppliersApi.md +313 -0
  114. data/docs/SuppliersRecord.md +38 -0
  115. data/docs/SuppliersResponse.md +58 -0
  116. data/docs/SuppliersRow.md +76 -0
  117. data/docs/TargetAssociationsResponse.md +58 -0
  118. data/docs/TargetAssociationsRow.md +26 -0
  119. data/docs/TargetCrowdingResponse.md +58 -0
  120. data/docs/TargetCrowdingRow.md +30 -0
  121. data/docs/TargetDrugsResponse.md +58 -0
  122. data/docs/TargetDrugsRow.md +38 -0
  123. data/docs/TargetEvidenceResponse.md +58 -0
  124. data/docs/TargetEvidenceRow.md +52 -0
  125. data/docs/TargetPatentMentionsResponse.md +58 -0
  126. data/docs/TargetPatentMentionsRow.md +34 -0
  127. data/docs/TargetProgramsResponse.md +58 -0
  128. data/docs/TargetProgramsRow.md +58 -0
  129. data/docs/TargetPublicationsResponse.md +58 -0
  130. data/docs/TargetPublicationsRow.md +32 -0
  131. data/docs/TargetRegulatoryPrecedentResponse.md +58 -0
  132. data/docs/TargetRegulatoryPrecedentRow.md +38 -0
  133. data/docs/TargetTrialsResponse.md +58 -0
  134. data/docs/TargetTrialsRow.md +46 -0
  135. data/docs/TargetsApi.md +1033 -0
  136. data/docs/TargetsRecord.md +38 -0
  137. data/docs/TargetsResponse.md +58 -0
  138. data/docs/TargetsRow.md +68 -0
  139. data/docs/TrialAdverseEventsResponse.md +3 -3
  140. data/docs/TrialChangesResponse.md +3 -3
  141. data/docs/TrialDeliveryResponse.md +3 -3
  142. data/docs/TrialDeliveryRow.md +7 -5
  143. data/docs/TrialDemographicsResponse.md +3 -3
  144. data/docs/TrialDrugClassesResponse.md +58 -0
  145. data/docs/TrialDrugClassesRow.md +28 -0
  146. data/docs/TrialDrugsResponse.md +3 -3
  147. data/docs/TrialEnrollmentHistoryResponse.md +3 -3
  148. data/docs/TrialEnrollmentRateResponse.md +3 -3
  149. data/docs/TrialEnrollmentRateRow.md +5 -3
  150. data/docs/TrialExtractedEndpointsResponse.md +3 -3
  151. data/docs/TrialKolsResponse.md +58 -0
  152. data/docs/TrialKolsRow.md +32 -0
  153. data/docs/TrialOutcomeMeasuresResponse.md +3 -3
  154. data/docs/TrialResearchPaymentsResponse.md +58 -0
  155. data/docs/TrialResearchPaymentsRow.md +44 -0
  156. data/docs/TrialSiteHistoryResponse.md +58 -0
  157. data/docs/TrialSiteHistoryRow.md +50 -0
  158. data/docs/TrialSitesResponse.md +3 -3
  159. data/docs/TrialsApi.md +320 -0
  160. data/docs/TrialsRecord.md +2 -2
  161. data/docs/TrialsResponse.md +3 -3
  162. data/docs/TrialsRow.md +3 -3
  163. data/lib/pharmaobservatory/api/biomarkers_api.rb +168 -0
  164. data/lib/pharmaobservatory/api/companies_api.rb +273 -0
  165. data/lib/pharmaobservatory/api/conditions_api.rb +252 -0
  166. data/lib/pharmaobservatory/api/investors_api.rb +665 -0
  167. data/lib/pharmaobservatory/api/legal_entities_api.rb +252 -0
  168. data/lib/pharmaobservatory/api/managers_api.rb +245 -0
  169. data/lib/pharmaobservatory/api/suppliers_api.rb +329 -0
  170. data/lib/pharmaobservatory/api/targets_api.rb +1085 -0
  171. data/lib/pharmaobservatory/api/trials_api.rb +336 -0
  172. data/lib/pharmaobservatory/models/api_v1_whoami_get200_response.rb +62 -4
  173. data/lib/pharmaobservatory/models/api_v1_whoami_get200_response_limits.rb +419 -0
  174. data/lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota.rb +263 -0
  175. data/lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota_buckets.rb +367 -0
  176. data/lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota_buckets_requests_per_minute.rb +367 -0
  177. data/lib/pharmaobservatory/models/biomarker_assay_evidence_response.rb +478 -0
  178. data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_build.rb → biomarker_assay_evidence_response_build.rb} +3 -3
  179. data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_freshness.rb → biomarker_assay_evidence_response_freshness.rb} +3 -3
  180. data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_scope.rb → biomarker_assay_evidence_response_scope.rb} +3 -3
  181. data/lib/pharmaobservatory/models/biomarker_assay_evidence_row.rb +506 -0
  182. data/lib/pharmaobservatory/models/biomarker_assay_whitespace_response.rb +478 -0
  183. data/lib/pharmaobservatory/models/biomarker_assay_whitespace_row.rb +499 -0
  184. data/lib/pharmaobservatory/models/biomarker_bqp_assertions_response.rb +3 -3
  185. data/lib/pharmaobservatory/models/biomarker_cdx_assertions_response.rb +3 -3
  186. data/lib/pharmaobservatory/models/biomarker_evidence_response.rb +3 -3
  187. data/lib/pharmaobservatory/models/biomarker_literature_response.rb +3 -3
  188. data/lib/pharmaobservatory/models/biomarker_publishing_companies_response.rb +3 -3
  189. data/lib/pharmaobservatory/models/biomarker_publishing_companies_row.rb +49 -5
  190. data/lib/pharmaobservatory/models/biomarker_relations_response.rb +3 -3
  191. data/lib/pharmaobservatory/models/biomarker_sample_coverage_response.rb +3 -3
  192. data/lib/pharmaobservatory/models/biomarker_sample_prevalence_response.rb +3 -3
  193. data/lib/pharmaobservatory/models/biomarker_validation_response.rb +3 -3
  194. data/lib/pharmaobservatory/models/biomarker_variant_mentions_response.rb +3 -3
  195. data/lib/pharmaobservatory/models/biomarkers_record.rb +2 -2
  196. data/lib/pharmaobservatory/models/biomarkers_response.rb +3 -3
  197. data/lib/pharmaobservatory/models/biomarkers_row.rb +12 -1
  198. data/lib/pharmaobservatory/models/cell_lines_record.rb +2 -2
  199. data/lib/pharmaobservatory/models/cell_lines_response.rb +3 -3
  200. data/lib/pharmaobservatory/models/companies_record.rb +2 -2
  201. data/lib/pharmaobservatory/models/companies_response.rb +3 -3
  202. data/lib/pharmaobservatory/models/companies_row.rb +1 -1
  203. data/lib/pharmaobservatory/models/company_assets_response.rb +3 -3
  204. data/lib/pharmaobservatory/models/company_funding_events_response.rb +3 -3
  205. data/lib/pharmaobservatory/models/company_funding_events_row.rb +1 -1
  206. data/lib/pharmaobservatory/models/company_funding_summary_response.rb +3 -3
  207. data/lib/pharmaobservatory/models/company_members_response.rb +3 -3
  208. data/lib/pharmaobservatory/models/company_programs_response.rb +3 -3
  209. data/lib/pharmaobservatory/models/company_targets_response.rb +3 -3
  210. data/lib/pharmaobservatory/models/company_targets_row.rb +27 -5
  211. data/lib/pharmaobservatory/models/condition_adverse_events_response.rb +3 -3
  212. data/lib/pharmaobservatory/models/condition_burden_response.rb +3 -3
  213. data/lib/pharmaobservatory/models/condition_delivery_response.rb +3 -3
  214. data/lib/pharmaobservatory/models/condition_drugs_response.rb +3 -3
  215. data/lib/pharmaobservatory/models/condition_prevalence_response.rb +3 -3
  216. data/lib/pharmaobservatory/models/condition_prevalence_row.rb +1 -1
  217. data/lib/pharmaobservatory/models/condition_publications_response.rb +3 -3
  218. data/lib/pharmaobservatory/models/condition_recruitment_by_phase_response.rb +478 -0
  219. data/lib/pharmaobservatory/models/condition_recruitment_by_phase_row.rb +399 -0
  220. data/lib/pharmaobservatory/models/condition_recruitment_duration_response.rb +478 -0
  221. data/lib/pharmaobservatory/models/condition_recruitment_duration_row.rb +597 -0
  222. data/lib/pharmaobservatory/models/condition_sites_response.rb +3 -3
  223. data/lib/pharmaobservatory/models/condition_trial_start_forecast_response.rb +478 -0
  224. data/lib/pharmaobservatory/models/condition_trial_start_forecast_row.rb +509 -0
  225. data/lib/pharmaobservatory/models/condition_trials_response.rb +3 -3
  226. data/lib/pharmaobservatory/models/condition_trials_row.rb +14 -3
  227. data/lib/pharmaobservatory/models/conditions_record.rb +2 -2
  228. data/lib/pharmaobservatory/models/conditions_record_attributes.rb +13 -4
  229. data/lib/pharmaobservatory/models/conditions_response.rb +3 -3
  230. data/lib/pharmaobservatory/models/drug_patent_cliff_response.rb +3 -3
  231. data/lib/pharmaobservatory/models/institutional_holdings_response.rb +3 -3
  232. data/lib/pharmaobservatory/models/institutional_holdings_row.rb +35 -2
  233. data/lib/pharmaobservatory/models/investor_funds_response.rb +478 -0
  234. data/lib/pharmaobservatory/models/investor_funds_row.rb +256 -0
  235. data/lib/pharmaobservatory/models/investor_portfolio_response.rb +478 -0
  236. data/lib/pharmaobservatory/models/investor_portfolio_row.rb +357 -0
  237. data/lib/pharmaobservatory/models/investor_private_funds_response.rb +478 -0
  238. data/lib/pharmaobservatory/models/investor_private_funds_row.rb +366 -0
  239. data/lib/pharmaobservatory/models/investors_record.rb +385 -0
  240. data/lib/pharmaobservatory/models/investors_response.rb +478 -0
  241. data/lib/pharmaobservatory/models/investors_row.rb +421 -0
  242. data/lib/pharmaobservatory/models/legal_entities_record.rb +2 -2
  243. data/lib/pharmaobservatory/models/legal_entities_response.rb +3 -3
  244. data/lib/pharmaobservatory/models/legal_entities_row.rb +1 -1
  245. data/lib/pharmaobservatory/models/managers_record.rb +385 -0
  246. data/lib/pharmaobservatory/models/managers_response.rb +478 -0
  247. data/lib/pharmaobservatory/models/managers_row.rb +377 -0
  248. data/lib/pharmaobservatory/models/org_disclosures_response.rb +478 -0
  249. data/lib/pharmaobservatory/models/org_disclosures_row.rb +432 -0
  250. data/lib/pharmaobservatory/models/org_relationships_response.rb +478 -0
  251. data/lib/pharmaobservatory/models/org_relationships_row.rb +498 -0
  252. data/lib/pharmaobservatory/models/ownership_positions_response.rb +3 -3
  253. data/lib/pharmaobservatory/models/ownership_positions_row.rb +26 -15
  254. data/lib/pharmaobservatory/models/pdufa_dates_response.rb +3 -3
  255. data/lib/pharmaobservatory/models/site_beds_yearly_response.rb +3 -3
  256. data/lib/pharmaobservatory/models/site_cro_trials_response.rb +3 -3
  257. data/lib/pharmaobservatory/models/site_hospitals_response.rb +3 -3
  258. data/lib/pharmaobservatory/models/site_investigators_response.rb +3 -3
  259. data/lib/pharmaobservatory/models/site_trial_conditions_response.rb +3 -3
  260. data/lib/pharmaobservatory/models/site_trial_drugs_response.rb +3 -3
  261. data/lib/pharmaobservatory/models/site_trials_response.rb +3 -3
  262. data/lib/pharmaobservatory/models/site_trials_row.rb +13 -2
  263. data/lib/pharmaobservatory/models/sites_record.rb +2 -2
  264. data/lib/pharmaobservatory/models/sites_response.rb +3 -3
  265. data/lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb +3 -3
  266. data/lib/pharmaobservatory/models/sponsor_recruitment_duration_response.rb +3 -3
  267. data/lib/pharmaobservatory/models/sponsor_trial_start_forecast_response.rb +3 -3
  268. data/lib/pharmaobservatory/models/sponsor_trials_response.rb +3 -3
  269. data/lib/pharmaobservatory/models/sponsor_trials_row.rb +14 -3
  270. data/lib/pharmaobservatory/models/supplier_capability_esg_response.rb +478 -0
  271. data/lib/pharmaobservatory/models/supplier_capability_esg_row.rb +480 -0
  272. data/lib/pharmaobservatory/models/supplier_services_response.rb +478 -0
  273. data/lib/pharmaobservatory/models/supplier_services_row.rb +289 -0
  274. data/lib/pharmaobservatory/models/supplier_sites_response.rb +478 -0
  275. data/lib/pharmaobservatory/models/supplier_sites_row.rb +357 -0
  276. data/lib/pharmaobservatory/models/suppliers_record.rb +385 -0
  277. data/lib/pharmaobservatory/models/suppliers_response.rb +478 -0
  278. data/lib/pharmaobservatory/models/suppliers_row.rb +544 -0
  279. data/lib/pharmaobservatory/models/target_associations_response.rb +478 -0
  280. data/lib/pharmaobservatory/models/target_associations_row.rb +267 -0
  281. data/lib/pharmaobservatory/models/target_crowding_response.rb +478 -0
  282. data/lib/pharmaobservatory/models/target_crowding_row.rb +289 -0
  283. data/lib/pharmaobservatory/models/target_drugs_response.rb +478 -0
  284. data/lib/pharmaobservatory/models/target_drugs_row.rb +335 -0
  285. data/lib/pharmaobservatory/models/target_evidence_response.rb +478 -0
  286. data/lib/pharmaobservatory/models/target_evidence_row.rb +410 -0
  287. data/lib/pharmaobservatory/models/target_patent_mentions_response.rb +478 -0
  288. data/lib/pharmaobservatory/models/target_patent_mentions_row.rb +311 -0
  289. data/lib/pharmaobservatory/models/target_programs_response.rb +478 -0
  290. data/lib/pharmaobservatory/models/target_programs_row.rb +447 -0
  291. data/lib/pharmaobservatory/models/target_publications_response.rb +478 -0
  292. data/lib/pharmaobservatory/models/target_publications_row.rb +300 -0
  293. data/lib/pharmaobservatory/models/target_regulatory_precedent_response.rb +478 -0
  294. data/lib/pharmaobservatory/models/target_regulatory_precedent_row.rb +333 -0
  295. data/lib/pharmaobservatory/models/target_trials_response.rb +478 -0
  296. data/lib/pharmaobservatory/models/target_trials_row.rb +377 -0
  297. data/lib/pharmaobservatory/models/targets_record.rb +385 -0
  298. data/lib/pharmaobservatory/models/targets_response.rb +478 -0
  299. data/lib/pharmaobservatory/models/targets_row.rb +498 -0
  300. data/lib/pharmaobservatory/models/trial_adverse_events_response.rb +3 -3
  301. data/lib/pharmaobservatory/models/trial_changes_response.rb +3 -3
  302. data/lib/pharmaobservatory/models/trial_delivery_response.rb +3 -3
  303. data/lib/pharmaobservatory/models/trial_delivery_row.rb +22 -11
  304. data/lib/pharmaobservatory/models/trial_demographics_response.rb +3 -3
  305. data/lib/pharmaobservatory/models/trial_drug_classes_response.rb +478 -0
  306. data/lib/pharmaobservatory/models/trial_drug_classes_row.rb +278 -0
  307. data/lib/pharmaobservatory/models/trial_drugs_response.rb +3 -3
  308. data/lib/pharmaobservatory/models/trial_enrollment_history_response.rb +3 -3
  309. data/lib/pharmaobservatory/models/trial_enrollment_rate_response.rb +3 -3
  310. data/lib/pharmaobservatory/models/trial_enrollment_rate_row.rb +15 -4
  311. data/lib/pharmaobservatory/models/trial_extracted_endpoints_response.rb +3 -3
  312. data/lib/pharmaobservatory/models/trial_kols_response.rb +478 -0
  313. data/lib/pharmaobservatory/models/trial_kols_row.rb +302 -0
  314. data/lib/pharmaobservatory/models/trial_outcome_measures_response.rb +3 -3
  315. data/lib/pharmaobservatory/models/trial_research_payments_response.rb +478 -0
  316. data/lib/pharmaobservatory/models/trial_research_payments_row.rb +366 -0
  317. data/lib/pharmaobservatory/models/trial_site_history_response.rb +478 -0
  318. data/lib/pharmaobservatory/models/trial_site_history_row.rb +401 -0
  319. data/lib/pharmaobservatory/models/trial_sites_response.rb +3 -3
  320. data/lib/pharmaobservatory/models/trials_record.rb +2 -2
  321. data/lib/pharmaobservatory/models/trials_response.rb +3 -3
  322. data/lib/pharmaobservatory/models/trials_row.rb +3 -3
  323. data/lib/pharmaobservatory/version.rb +1 -1
  324. data/lib/pharmaobservatory.rb +75 -3
  325. metadata +152 -8
metadata CHANGED
@@ -1,14 +1,14 @@
1
1
  --- !ruby/object:Gem::Specification
2
2
  name: pharmaobservatory
3
3
  version: !ruby/object:Gem::Version
4
- version: 0.1.4
4
+ version: 0.1.6
5
5
  platform: ruby
6
6
  authors:
7
7
  - Scientist.com
8
8
  autorequire:
9
9
  bindir: bin
10
10
  cert_chain: []
11
- date: 2026-10-19 00:00:00.000000000 Z
11
+ date: 2026-10-21 00:00:00.000000000 Z
12
12
  dependencies:
13
13
  - !ruby/object:Gem::Dependency
14
14
  name: faraday
@@ -89,13 +89,21 @@ files:
89
89
  - README.md
90
90
  - docs/ApiV1BaseApi.md
91
91
  - docs/ApiV1WhoamiGet200Response.md
92
+ - docs/ApiV1WhoamiGet200ResponseLimits.md
93
+ - docs/ApiV1WhoamiGet200ResponseQuota.md
94
+ - docs/ApiV1WhoamiGet200ResponseQuotaBuckets.md
95
+ - docs/ApiV1WhoamiGet200ResponseQuotaBucketsRequestsPerMinute.md
92
96
  - docs/AuthError.md
97
+ - docs/BiomarkerAssayEvidenceResponse.md
98
+ - docs/BiomarkerAssayEvidenceResponseBuild.md
99
+ - docs/BiomarkerAssayEvidenceResponseFreshness.md
100
+ - docs/BiomarkerAssayEvidenceResponseScope.md
101
+ - docs/BiomarkerAssayEvidenceRow.md
102
+ - docs/BiomarkerAssayWhitespaceResponse.md
103
+ - docs/BiomarkerAssayWhitespaceRow.md
93
104
  - docs/BiomarkerBqpAssertionsResponse.md
94
105
  - docs/BiomarkerBqpAssertionsRow.md
95
106
  - docs/BiomarkerCdxAssertionsResponse.md
96
- - docs/BiomarkerCdxAssertionsResponseBuild.md
97
- - docs/BiomarkerCdxAssertionsResponseFreshness.md
98
- - docs/BiomarkerCdxAssertionsResponseScope.md
99
107
  - docs/BiomarkerCdxAssertionsRow.md
100
108
  - docs/BiomarkerEvidenceResponse.md
101
109
  - docs/BiomarkerEvidenceRow.md
@@ -150,8 +158,14 @@ files:
150
158
  - docs/ConditionPrevalenceRow.md
151
159
  - docs/ConditionPublicationsResponse.md
152
160
  - docs/ConditionPublicationsRow.md
161
+ - docs/ConditionRecruitmentByPhaseResponse.md
162
+ - docs/ConditionRecruitmentByPhaseRow.md
163
+ - docs/ConditionRecruitmentDurationResponse.md
164
+ - docs/ConditionRecruitmentDurationRow.md
153
165
  - docs/ConditionSitesResponse.md
154
166
  - docs/ConditionSitesRow.md
167
+ - docs/ConditionTrialStartForecastResponse.md
168
+ - docs/ConditionTrialStartForecastRow.md
155
169
  - docs/ConditionTrialsResponse.md
156
170
  - docs/ConditionTrialsRow.md
157
171
  - docs/ConditionsApi.md
@@ -170,11 +184,29 @@ files:
170
184
  - docs/DrugPatentCliffRow.md
171
185
  - docs/InstitutionalHoldingsResponse.md
172
186
  - docs/InstitutionalHoldingsRow.md
187
+ - docs/InvestorFundsResponse.md
188
+ - docs/InvestorFundsRow.md
189
+ - docs/InvestorPortfolioResponse.md
190
+ - docs/InvestorPortfolioRow.md
191
+ - docs/InvestorPrivateFundsResponse.md
192
+ - docs/InvestorPrivateFundsRow.md
193
+ - docs/InvestorsApi.md
194
+ - docs/InvestorsRecord.md
195
+ - docs/InvestorsResponse.md
196
+ - docs/InvestorsRow.md
173
197
  - docs/LegalEntitiesApi.md
174
198
  - docs/LegalEntitiesRecord.md
175
199
  - docs/LegalEntitiesRecordAttributes.md
176
200
  - docs/LegalEntitiesResponse.md
177
201
  - docs/LegalEntitiesRow.md
202
+ - docs/ManagersApi.md
203
+ - docs/ManagersRecord.md
204
+ - docs/ManagersResponse.md
205
+ - docs/ManagersRow.md
206
+ - docs/OrgDisclosuresResponse.md
207
+ - docs/OrgDisclosuresRow.md
208
+ - docs/OrgRelationshipsResponse.md
209
+ - docs/OrgRelationshipsRow.md
178
210
  - docs/OwnershipPositionsResponse.md
179
211
  - docs/OwnershipPositionsRow.md
180
212
  - docs/PdufaDatesResponse.md
@@ -212,6 +244,38 @@ files:
212
244
  - docs/SponsorTrialStartForecastRow.md
213
245
  - docs/SponsorTrialsResponse.md
214
246
  - docs/SponsorTrialsRow.md
247
+ - docs/SupplierCapabilityEsgResponse.md
248
+ - docs/SupplierCapabilityEsgRow.md
249
+ - docs/SupplierServicesResponse.md
250
+ - docs/SupplierServicesRow.md
251
+ - docs/SupplierSitesResponse.md
252
+ - docs/SupplierSitesRow.md
253
+ - docs/SuppliersApi.md
254
+ - docs/SuppliersRecord.md
255
+ - docs/SuppliersResponse.md
256
+ - docs/SuppliersRow.md
257
+ - docs/TargetAssociationsResponse.md
258
+ - docs/TargetAssociationsRow.md
259
+ - docs/TargetCrowdingResponse.md
260
+ - docs/TargetCrowdingRow.md
261
+ - docs/TargetDrugsResponse.md
262
+ - docs/TargetDrugsRow.md
263
+ - docs/TargetEvidenceResponse.md
264
+ - docs/TargetEvidenceRow.md
265
+ - docs/TargetPatentMentionsResponse.md
266
+ - docs/TargetPatentMentionsRow.md
267
+ - docs/TargetProgramsResponse.md
268
+ - docs/TargetProgramsRow.md
269
+ - docs/TargetPublicationsResponse.md
270
+ - docs/TargetPublicationsRow.md
271
+ - docs/TargetRegulatoryPrecedentResponse.md
272
+ - docs/TargetRegulatoryPrecedentRow.md
273
+ - docs/TargetTrialsResponse.md
274
+ - docs/TargetTrialsRow.md
275
+ - docs/TargetsApi.md
276
+ - docs/TargetsRecord.md
277
+ - docs/TargetsResponse.md
278
+ - docs/TargetsRow.md
215
279
  - docs/TrialAdverseEventsResponse.md
216
280
  - docs/TrialAdverseEventsRow.md
217
281
  - docs/TrialChangesResponse.md
@@ -220,6 +284,8 @@ files:
220
284
  - docs/TrialDeliveryRow.md
221
285
  - docs/TrialDemographicsResponse.md
222
286
  - docs/TrialDemographicsRow.md
287
+ - docs/TrialDrugClassesResponse.md
288
+ - docs/TrialDrugClassesRow.md
223
289
  - docs/TrialDrugsResponse.md
224
290
  - docs/TrialDrugsRow.md
225
291
  - docs/TrialEnrollmentHistoryResponse.md
@@ -228,8 +294,14 @@ files:
228
294
  - docs/TrialEnrollmentRateRow.md
229
295
  - docs/TrialExtractedEndpointsResponse.md
230
296
  - docs/TrialExtractedEndpointsRow.md
297
+ - docs/TrialKolsResponse.md
298
+ - docs/TrialKolsRow.md
231
299
  - docs/TrialOutcomeMeasuresResponse.md
232
300
  - docs/TrialOutcomeMeasuresRow.md
301
+ - docs/TrialResearchPaymentsResponse.md
302
+ - docs/TrialResearchPaymentsRow.md
303
+ - docs/TrialSiteHistoryResponse.md
304
+ - docs/TrialSiteHistoryRow.md
233
305
  - docs/TrialSitesResponse.md
234
306
  - docs/TrialSitesRow.md
235
307
  - docs/TrialsApi.md
@@ -244,21 +316,33 @@ files:
244
316
  - lib/pharmaobservatory/api/companies_api.rb
245
317
  - lib/pharmaobservatory/api/conditions_api.rb
246
318
  - lib/pharmaobservatory/api/datasets_api.rb
319
+ - lib/pharmaobservatory/api/investors_api.rb
247
320
  - lib/pharmaobservatory/api/legal_entities_api.rb
321
+ - lib/pharmaobservatory/api/managers_api.rb
248
322
  - lib/pharmaobservatory/api/query_api.rb
249
323
  - lib/pharmaobservatory/api/sites_api.rb
324
+ - lib/pharmaobservatory/api/suppliers_api.rb
325
+ - lib/pharmaobservatory/api/targets_api.rb
250
326
  - lib/pharmaobservatory/api/trials_api.rb
251
327
  - lib/pharmaobservatory/api_client.rb
252
328
  - lib/pharmaobservatory/api_error.rb
253
329
  - lib/pharmaobservatory/configuration.rb
254
330
  - lib/pharmaobservatory/models/api_v1_whoami_get200_response.rb
331
+ - lib/pharmaobservatory/models/api_v1_whoami_get200_response_limits.rb
332
+ - lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota.rb
333
+ - lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota_buckets.rb
334
+ - lib/pharmaobservatory/models/api_v1_whoami_get200_response_quota_buckets_requests_per_minute.rb
255
335
  - lib/pharmaobservatory/models/auth_error.rb
336
+ - lib/pharmaobservatory/models/biomarker_assay_evidence_response.rb
337
+ - lib/pharmaobservatory/models/biomarker_assay_evidence_response_build.rb
338
+ - lib/pharmaobservatory/models/biomarker_assay_evidence_response_freshness.rb
339
+ - lib/pharmaobservatory/models/biomarker_assay_evidence_response_scope.rb
340
+ - lib/pharmaobservatory/models/biomarker_assay_evidence_row.rb
341
+ - lib/pharmaobservatory/models/biomarker_assay_whitespace_response.rb
342
+ - lib/pharmaobservatory/models/biomarker_assay_whitespace_row.rb
256
343
  - lib/pharmaobservatory/models/biomarker_bqp_assertions_response.rb
257
344
  - lib/pharmaobservatory/models/biomarker_bqp_assertions_row.rb
258
345
  - lib/pharmaobservatory/models/biomarker_cdx_assertions_response.rb
259
- - lib/pharmaobservatory/models/biomarker_cdx_assertions_response_build.rb
260
- - lib/pharmaobservatory/models/biomarker_cdx_assertions_response_freshness.rb
261
- - lib/pharmaobservatory/models/biomarker_cdx_assertions_response_scope.rb
262
346
  - lib/pharmaobservatory/models/biomarker_cdx_assertions_row.rb
263
347
  - lib/pharmaobservatory/models/biomarker_evidence_response.rb
264
348
  - lib/pharmaobservatory/models/biomarker_evidence_row.rb
@@ -310,8 +394,14 @@ files:
310
394
  - lib/pharmaobservatory/models/condition_prevalence_row.rb
311
395
  - lib/pharmaobservatory/models/condition_publications_response.rb
312
396
  - lib/pharmaobservatory/models/condition_publications_row.rb
397
+ - lib/pharmaobservatory/models/condition_recruitment_by_phase_response.rb
398
+ - lib/pharmaobservatory/models/condition_recruitment_by_phase_row.rb
399
+ - lib/pharmaobservatory/models/condition_recruitment_duration_response.rb
400
+ - lib/pharmaobservatory/models/condition_recruitment_duration_row.rb
313
401
  - lib/pharmaobservatory/models/condition_sites_response.rb
314
402
  - lib/pharmaobservatory/models/condition_sites_row.rb
403
+ - lib/pharmaobservatory/models/condition_trial_start_forecast_response.rb
404
+ - lib/pharmaobservatory/models/condition_trial_start_forecast_row.rb
315
405
  - lib/pharmaobservatory/models/condition_trials_response.rb
316
406
  - lib/pharmaobservatory/models/condition_trials_row.rb
317
407
  - lib/pharmaobservatory/models/conditions_record.rb
@@ -328,10 +418,26 @@ files:
328
418
  - lib/pharmaobservatory/models/drug_patent_cliff_row.rb
329
419
  - lib/pharmaobservatory/models/institutional_holdings_response.rb
330
420
  - lib/pharmaobservatory/models/institutional_holdings_row.rb
421
+ - lib/pharmaobservatory/models/investor_funds_response.rb
422
+ - lib/pharmaobservatory/models/investor_funds_row.rb
423
+ - lib/pharmaobservatory/models/investor_portfolio_response.rb
424
+ - lib/pharmaobservatory/models/investor_portfolio_row.rb
425
+ - lib/pharmaobservatory/models/investor_private_funds_response.rb
426
+ - lib/pharmaobservatory/models/investor_private_funds_row.rb
427
+ - lib/pharmaobservatory/models/investors_record.rb
428
+ - lib/pharmaobservatory/models/investors_response.rb
429
+ - lib/pharmaobservatory/models/investors_row.rb
331
430
  - lib/pharmaobservatory/models/legal_entities_record.rb
332
431
  - lib/pharmaobservatory/models/legal_entities_record_attributes.rb
333
432
  - lib/pharmaobservatory/models/legal_entities_response.rb
334
433
  - lib/pharmaobservatory/models/legal_entities_row.rb
434
+ - lib/pharmaobservatory/models/managers_record.rb
435
+ - lib/pharmaobservatory/models/managers_response.rb
436
+ - lib/pharmaobservatory/models/managers_row.rb
437
+ - lib/pharmaobservatory/models/org_disclosures_response.rb
438
+ - lib/pharmaobservatory/models/org_disclosures_row.rb
439
+ - lib/pharmaobservatory/models/org_relationships_response.rb
440
+ - lib/pharmaobservatory/models/org_relationships_row.rb
335
441
  - lib/pharmaobservatory/models/ownership_positions_response.rb
336
442
  - lib/pharmaobservatory/models/ownership_positions_row.rb
337
443
  - lib/pharmaobservatory/models/pdufa_dates_response.rb
@@ -367,6 +473,36 @@ files:
367
473
  - lib/pharmaobservatory/models/sponsor_trial_start_forecast_row.rb
368
474
  - lib/pharmaobservatory/models/sponsor_trials_response.rb
369
475
  - lib/pharmaobservatory/models/sponsor_trials_row.rb
476
+ - lib/pharmaobservatory/models/supplier_capability_esg_response.rb
477
+ - lib/pharmaobservatory/models/supplier_capability_esg_row.rb
478
+ - lib/pharmaobservatory/models/supplier_services_response.rb
479
+ - lib/pharmaobservatory/models/supplier_services_row.rb
480
+ - lib/pharmaobservatory/models/supplier_sites_response.rb
481
+ - lib/pharmaobservatory/models/supplier_sites_row.rb
482
+ - lib/pharmaobservatory/models/suppliers_record.rb
483
+ - lib/pharmaobservatory/models/suppliers_response.rb
484
+ - lib/pharmaobservatory/models/suppliers_row.rb
485
+ - lib/pharmaobservatory/models/target_associations_response.rb
486
+ - lib/pharmaobservatory/models/target_associations_row.rb
487
+ - lib/pharmaobservatory/models/target_crowding_response.rb
488
+ - lib/pharmaobservatory/models/target_crowding_row.rb
489
+ - lib/pharmaobservatory/models/target_drugs_response.rb
490
+ - lib/pharmaobservatory/models/target_drugs_row.rb
491
+ - lib/pharmaobservatory/models/target_evidence_response.rb
492
+ - lib/pharmaobservatory/models/target_evidence_row.rb
493
+ - lib/pharmaobservatory/models/target_patent_mentions_response.rb
494
+ - lib/pharmaobservatory/models/target_patent_mentions_row.rb
495
+ - lib/pharmaobservatory/models/target_programs_response.rb
496
+ - lib/pharmaobservatory/models/target_programs_row.rb
497
+ - lib/pharmaobservatory/models/target_publications_response.rb
498
+ - lib/pharmaobservatory/models/target_publications_row.rb
499
+ - lib/pharmaobservatory/models/target_regulatory_precedent_response.rb
500
+ - lib/pharmaobservatory/models/target_regulatory_precedent_row.rb
501
+ - lib/pharmaobservatory/models/target_trials_response.rb
502
+ - lib/pharmaobservatory/models/target_trials_row.rb
503
+ - lib/pharmaobservatory/models/targets_record.rb
504
+ - lib/pharmaobservatory/models/targets_response.rb
505
+ - lib/pharmaobservatory/models/targets_row.rb
370
506
  - lib/pharmaobservatory/models/trial_adverse_events_response.rb
371
507
  - lib/pharmaobservatory/models/trial_adverse_events_row.rb
372
508
  - lib/pharmaobservatory/models/trial_changes_response.rb
@@ -375,6 +511,8 @@ files:
375
511
  - lib/pharmaobservatory/models/trial_delivery_row.rb
376
512
  - lib/pharmaobservatory/models/trial_demographics_response.rb
377
513
  - lib/pharmaobservatory/models/trial_demographics_row.rb
514
+ - lib/pharmaobservatory/models/trial_drug_classes_response.rb
515
+ - lib/pharmaobservatory/models/trial_drug_classes_row.rb
378
516
  - lib/pharmaobservatory/models/trial_drugs_response.rb
379
517
  - lib/pharmaobservatory/models/trial_drugs_row.rb
380
518
  - lib/pharmaobservatory/models/trial_enrollment_history_response.rb
@@ -383,8 +521,14 @@ files:
383
521
  - lib/pharmaobservatory/models/trial_enrollment_rate_row.rb
384
522
  - lib/pharmaobservatory/models/trial_extracted_endpoints_response.rb
385
523
  - lib/pharmaobservatory/models/trial_extracted_endpoints_row.rb
524
+ - lib/pharmaobservatory/models/trial_kols_response.rb
525
+ - lib/pharmaobservatory/models/trial_kols_row.rb
386
526
  - lib/pharmaobservatory/models/trial_outcome_measures_response.rb
387
527
  - lib/pharmaobservatory/models/trial_outcome_measures_row.rb
528
+ - lib/pharmaobservatory/models/trial_research_payments_response.rb
529
+ - lib/pharmaobservatory/models/trial_research_payments_row.rb
530
+ - lib/pharmaobservatory/models/trial_site_history_response.rb
531
+ - lib/pharmaobservatory/models/trial_site_history_row.rb
388
532
  - lib/pharmaobservatory/models/trial_sites_response.rb
389
533
  - lib/pharmaobservatory/models/trial_sites_row.rb
390
534
  - lib/pharmaobservatory/models/trials_record.rb